Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

被引:182
作者
Nardelli-Haefliger, D
Wirthner, D
Schiller, JT
Lowy, DR
Hildesheim, A
Ponci, F
De Grandi, P
机构
[1] NCI, Cellular Oncol Lab, Ctr Canc Res, Bethesda, MD 20892 USA
[2] CHU Vaudois, Dept Gynecol, CH-1011 Lausanne, Switzerland
[3] NCI, Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 15期
关键词
D O I
10.1093/jnci/djg018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In early-phase trials, a human papillomavirus 16 (HPV16) virus-like particle (VLP) vaccine has been shown to be well tolerated, immunogenic, and protective against HPV16 in women, most of whom were taking oral contraceptives. Previous studies have not determined whether HPV immunization results in specific antibody levels in the human genital tract or whether these levels might vary during contraceptive or ovulatory cycles. Therefore, we determined the levels of total and specific antibodies in the cervical secretions of women who had been immunized with HPV16 VLPs and examined the influence of the menstrual cycle and oral contraceptive use on these levels. Methods: Two groups of women were immunized, seven who were taking oral contraceptives and 11 who were ovulating. After seroconversion, serum and cervical secretions were collected twice weekly for 5 weeks. Total immunoglobulins (IgG and IgA) and vaccine-specific IgGs were determined by enzyme-linked immunosorbent assay. Nonparametric statistical analyses were used to determine the statistical significance of differences in IgG levels between groups, and correlations between serum- and cervical-specific IgG levels were determined by the Spearman correlation coefficient. Results: All participants developed detectable titers of anti-HPV16 VLP IgGs in their cervical secretions after immunization. The cervical titers of specific IgG and total IgGs and IgAs among participants in the contraceptive group were relatively constant throughout the contraceptive cycle. In contrast, the cervical titers of specific IgG and total IgGs and IgAs among participants in the ovulatory group varied during the menstrual cycle, being highest during the proliferative phase, decreasing approximately ninefold around ovulation, and increasing approximately threefold during the luteal phase. Serum- and cervical-specific IgG levels were correlated (r = .86) in women in the contraceptive group but not in women in the ovulatory group (r = .27). Conclusions: The relatively high titer of anti-HPV16 antibodies at the cervix is promising in terms of vaccine efficacy; however, the decrease in antibody titer around ovulation raises the possibility that the HPV16 VLP vaccine might be less effective during the peri-ovulatory phase.
引用
收藏
页码:1128 / 1137
页数:10
相关论文
共 45 条
  • [1] Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
    Balmelli, C
    Roden, R
    Potts, A
    Schiller, J
    De Grandi, P
    Nardelli-Haefliger, D
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (10) : 8220 - 8229
  • [2] Herpes simplex virus vaccines
    Bernstein, DI
    Stanberry, LR
    [J]. VACCINE, 1999, 17 (13-14) : 1681 - 1689
  • [3] IMMUNOGLOBULIN-G ANTIBODIES IN HUMAN VAGINAL SECRETIONS AFTER PARENTERAL VACCINATION
    BOUVET, JP
    BELEC, L
    PIRES, R
    PILLOT, J
    [J]. INFECTION AND IMMUNITY, 1994, 62 (09) : 3957 - 3961
  • [4] Mucosal immunity in the female genital tract
    Brandtzaeg, P
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1997, 36 (1-2) : 23 - 50
  • [5] IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION
    BREITBURD, F
    KIRNBAUER, R
    HUBBERT, NL
    NONNENMACHER, B
    TRINDINHDESMARQUET, C
    ORTH, G
    SCHILLER, JT
    LOWY, DR
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3959 - 3963
  • [6] Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: Correlation with competitive radioimmunoassay titer
    Brown, DR
    Bryan, JT
    Schroeder, JM
    Robinson, TS
    Fife, KH
    Wheeler, CM
    Barr, E
    Smith, PR
    Chiacchierini, L
    DiCello, A
    Jansen, KU
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (09) : 1183 - 1186
  • [7] Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
    Christensen, ND
    Reed, CA
    Cladel, NM
    Han, R
    Kreider, JW
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 960 - 965
  • [8] COTTINGHAM J, 1992, GENITOURIN MED, V68, P209
  • [9] Rectal immunization for induction of specific antibody in the genital tract of women
    CrowleyNowick, PA
    Bell, MC
    Brockwell, R
    Edwards, RP
    Chen, S
    Partridge, EE
    Mestecky, J
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (05) : 370 - 379
  • [10] Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens
    Decroix, N
    Hocini, H
    Quan, CP
    Bellon, B
    Kazatchkine, MD
    Bouvet, JP
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 53 (04) : 401 - 409